Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5462 | 1620 | 51.4 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
212 | 3 | GASTROENTEROLOGY & HEPATOLOGY//LAPAROSCOPIC CHOLECYSTECTOMY//PRIMARY BILIARY CIRRHOSIS | 51420 |
1019 | 2 | BILE ACIDS//FARNESOID X RECEPTOR//CHOLESTASIS | 10277 |
5462 | 1 | FARNESOID X RECEPTOR//FXR//TGR5 | 1620 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FARNESOID X RECEPTOR | authKW | 2684813 | 13% | 69% | 205 |
2 | FXR | authKW | 1535570 | 8% | 60% | 136 |
3 | TGR5 | authKW | 1050551 | 4% | 77% | 72 |
4 | BILE ACIDS | authKW | 580826 | 19% | 10% | 304 |
5 | SMALL HETERODIMER PARTNER | authKW | 480979 | 2% | 73% | 35 |
6 | FARNESOID X RECEPTOR FXR | authKW | 368599 | 2% | 67% | 29 |
7 | GW4064 | authKW | 314115 | 1% | 83% | 20 |
8 | EXPT MOL HEPATOL | address | 205815 | 2% | 38% | 29 |
9 | BILE ACID RECEPTOR | authKW | 193854 | 1% | 86% | 12 |
10 | NUCLEAR RECEPTOR | authKW | 179398 | 10% | 6% | 160 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 8344 | 22% | 0% | 358 |
2 | Biochemistry & Molecular Biology | 1842 | 31% | 0% | 495 |
3 | Endocrinology & Metabolism | 1496 | 13% | 0% | 206 |
4 | Chemistry, Medicinal | 1234 | 9% | 0% | 143 |
5 | Pharmacology & Pharmacy | 752 | 15% | 0% | 240 |
6 | Cell Biology | 591 | 12% | 0% | 188 |
7 | Physiology | 389 | 6% | 0% | 102 |
8 | Biophysics | 187 | 5% | 0% | 81 |
9 | Medicine, Research & Experimental | 113 | 4% | 0% | 70 |
10 | Toxicology | 89 | 3% | 0% | 49 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPT MOL HEPATOL | 205815 | 2% | 38% | 29 |
2 | GENE REGULAT DRUG DISCOVERY | 165023 | 1% | 49% | 18 |
3 | PHARMACEUT DEV PHYS PROPERTIES DEVELOPABIL | 78529 | 0% | 83% | 5 |
4 | INTEGRAT MED SCI | 60077 | 2% | 9% | 37 |
5 | MOL DISCOVERY BIOL REAGENTS ASSAY DEV | 56542 | 0% | 100% | 3 |
6 | MOL DISCOVERY COMPUTAT STRUCT CHEM | 56542 | 0% | 100% | 3 |
7 | LIVER DIGEST METAB DIS | 55562 | 2% | 9% | 33 |
8 | UNITE RECH 545 | 52349 | 0% | 56% | 5 |
9 | TEXAS CHILDRENS LIVER | 52339 | 1% | 28% | 10 |
10 | PHARMACOL TOXICOL THER EUT | 48253 | 3% | 5% | 52 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 10445 | 4% | 1% | 59 |
2 | HEPATOLOGY | 7706 | 4% | 1% | 70 |
3 | JOURNAL OF LIPID RESEARCH | 6870 | 3% | 1% | 56 |
4 | MOLECULAR ENDOCRINOLOGY | 4054 | 2% | 1% | 35 |
5 | DIGESTIVE DISEASES | 3877 | 1% | 1% | 19 |
6 | CELL METABOLISM | 2889 | 1% | 1% | 15 |
7 | JOURNAL OF HEPATOLOGY | 2496 | 2% | 0% | 32 |
8 | GASTROENTEROLOGY | 1322 | 2% | 0% | 31 |
9 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1275 | 7% | 0% | 107 |
10 | JOURNAL OF MEDICINAL CHEMISTRY | 690 | 2% | 0% | 29 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FARNESOID X RECEPTOR | 2684813 | 13% | 69% | 205 | Search FARNESOID+X+RECEPTOR | Search FARNESOID+X+RECEPTOR |
2 | FXR | 1535570 | 8% | 60% | 136 | Search FXR | Search FXR |
3 | TGR5 | 1050551 | 4% | 77% | 72 | Search TGR5 | Search TGR5 |
4 | BILE ACIDS | 580826 | 19% | 10% | 304 | Search BILE+ACIDS | Search BILE+ACIDS |
5 | SMALL HETERODIMER PARTNER | 480979 | 2% | 73% | 35 | Search SMALL+HETERODIMER+PARTNER | Search SMALL+HETERODIMER+PARTNER |
6 | FARNESOID X RECEPTOR FXR | 368599 | 2% | 67% | 29 | Search FARNESOID+X+RECEPTOR+FXR | Search FARNESOID+X+RECEPTOR+FXR |
7 | GW4064 | 314115 | 1% | 83% | 20 | Search GW4064 | Search GW4064 |
8 | BILE ACID RECEPTOR | 193854 | 1% | 86% | 12 | Search BILE+ACID+RECEPTOR | Search BILE+ACID+RECEPTOR |
9 | NUCLEAR RECEPTOR | 179398 | 10% | 6% | 160 | Search NUCLEAR+RECEPTOR | Search NUCLEAR+RECEPTOR |
10 | GPBAR1 | 162890 | 1% | 79% | 11 | Search GPBAR1 | Search GPBAR1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MAZUY, C , HELLEBOID, A , STAELS, B , LEFEBVRE, P , (2015) NUCLEAR BILE ACID SIGNALING THROUGH THE FARNESOID X RECEPTOR.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 72. ISSUE 9. P. 1631 -1650 | 150 | 70% | 13 |
2 | LEFEBVRE, P , CARIOU, B , LIEN, F , KUIPERS, F , STAELS, B , (2009) ROLE OF BILE ACIDS AND BILE ACID RECEPTORS IN METABOLIC REGULATION.PHYSIOLOGICAL REVIEWS. VOL. 89. ISSUE 1. P. 147 -191 | 156 | 46% | 495 |
3 | LI, TG , CHIANG, JYL , (2014) BILE ACID SIGNALING IN METABOLIC DISEASE AND DRUG THERAPY.PHARMACOLOGICAL REVIEWS. VOL. 66. ISSUE 4. P. 948 -983 | 167 | 41% | 46 |
4 | POREZ, G , PRAWITT, J , GROSS, B , STAELS, B , (2012) BILE ACID RECEPTORS AS TARGETS FOR THE TREATMENT OF DYSLIPIDEMIA AND CARDIOVASCULAR DISEASE.JOURNAL OF LIPID RESEARCH. VOL. 53. ISSUE 9. P. 1723 -1737 | 108 | 69% | 75 |
5 | MATSUBARA, T , LI, F , GONZALEZ, FJ , (2013) FXR SIGNALING IN THE ENTEROHEPATIC SYSTEM.MOLECULAR AND CELLULAR ENDOCRINOLOGY. VOL. 368. ISSUE 1-2. P. 17-29 | 98 | 70% | 57 |
6 | THOMAS, C , PELLICCIARI, R , PRUZANSKI, M , AUWERX, J , SCHOONJANS, K , (2008) TARGETING BILE-ACID SIGNALLING FOR METABOLIC DISEASES.NATURE REVIEWS DRUG DISCOVERY. VOL. 7. ISSUE 8. P. 678 -693 | 90 | 62% | 376 |
7 | XU, YP , (2016) RECENT PROGRESS ON BILE ACID RECEPTOR MODULATORS FOR TREATMENT OF METABOLIC DISEASES.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 14. P. 6553 -6579 | 74 | 93% | 1 |
8 | SCHAAP, FG , TRAUNER, M , JANSEN, PLM , (2014) BILE ACID RECEPTORS AS TARGETS FOR DRUG DEVELOPMENT.NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY. VOL. 11. ISSUE 1. P. 55-67 | 86 | 54% | 89 |
9 | FIORUCCI, S , MENCARELLI, A , DISTRUTTI, E , PALLADINO, G , CIPRIANI, S , (2010) TARGETING FARNESOID-X-RECEPTOR: FROM MEDICINAL CHEMISTRY TO DISEASE TREATMENT.CURRENT MEDICINAL CHEMISTRY. VOL. 17. ISSUE 2. P. 139-159 | 98 | 75% | 40 |
10 | LAMERS, C , SCHUBERT-ZSILAVECZ, M , MERK, D , (2014) MEDICINAL CHEMISTRY AND PHARMACOLOGICAL EFFECTS OF FARNESOID X RECEPTOR (FXR) ANTAGONISTS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 14. ISSUE 19. P. 2188 -2205 | 92 | 79% | 2 |
Classes with closest relation at Level 1 |